Literature DB >> 8752613

Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome.

A Revel1, V Barak, Y Lavy, E Anteby, Y Abramov, J J Schenker, A Amit, Z Finci-Yeheskel, M Mayer, A Simon, N Laufer, A Hurwitz.   

Abstract

OBJECTIVE: To assess the potential involvement of cytokines and nitrites in the hyperpermeability characterizing the ovarian hyperstimulation syndrome (OHSS).
DESIGN: A controlled clinical study comparing peritoneal fluid (PF) from patients with severe OHSS and from non-OHSS controls.
SETTING: Women hospitalized with severe OHSS in three tertiary medical centers. PATIENTS: Twelve patients with severe OHSS necessitating paracentesis and 20 non-OHSS controls.
INTERVENTIONS: The criteria for ultrasound-guided paracentesis were tense ascites, hydrothorax, hemoconcentration, or oliguria. MAIN OUTCOME MEASURES: Interleukin (IL) 1 beta IL-1 receptor agonist, IL-2, IL-6, IL-8, and tumor necrosis factor alpha (TNF alpha) levels in PF were assayed by ELISA; nitrites were measured by the "Griess" reaction. Estradiol and P were determined by RIA.
RESULTS: Ovarian hyperstimulation syndrome patients had significantly higher PF IL-6 (3,523 versus 30 pg/mL), TNF alpha (14 versus 4.2 pg/mL), and IL-8 (1,695 versus 900 pg/mL). In the serum, only IL-6 levels were significantly higher (375 versus 11 pg/mL). Conversely, nitrite levels were significantly lower in PF of OHSS patients (0.5 versus 34 nmol/mL). Interleukin 1 levels were higher and IL-1 receptor antagonist levels were lower in OHSS patients, suggesting potentially increased biologic potency of IL-1.
CONCLUSION: These findings suggest that these substances could be involved in mediating the capillary hyperpermeability characterizing this syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752613

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

2.  Cytokines in older patients undergoing in vitro fertilization: the relationship to the response to controlled ovarian hyperstimulation.

Authors:  A Pellicer; N Garrido; C Albert; J Navarro; J Remohí; C Simón
Journal:  J Assist Reprod Genet       Date:  1999-05       Impact factor: 3.412

3.  Relationships between concentrations of tumor necrosis factor-alpha and nitric oxide in follicular fluid and oocyte quality.

Authors:  K S Lee; B S Joo; Y J Na; M S Yoon; O H Choi; W W Kim
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

4.  The role of intravenous immunoglobulin in the prevention of severe ovarian hyperstimulation syndrome.

Authors:  R Orvieto; A Achiron; R Margalit; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

5.  A Rare Case of Ovarian Hyperstimulation Syndrome in a Preterm Infant.

Authors:  Asieh Mosallanejad; Shahrzad Tabatabai; Marjan Shakiba; Mohammad Reza Alaei; Hedieh Saneifard
Journal:  J Clin Diagn Res       Date:  2016-11-01

6.  A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome.

Authors:  S Ogawa; H Minakami; S Araki; T Ohno; M Motoyama; H Shibahara; I Sato
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

7.  Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome.

Authors:  Miaad Jabbar Alhilali; Abbas Parham; Armin Attaranzadeh; Malihe Amirian; Mohammad Azizzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2020-11-12       Impact factor: 3.007

8.  Progesterone-induced blocking factor 1 and cytokine profile of follicular fluid of infertile women qualified to in vitro fertilization: The influence on fetus development and pregnancy outcome.

Authors:  Rafał Adamczak; Natalia Ukleja-Sokołowska; Kinga Lis; Zbigniew Bartuzi; Mariusz Dubiel
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

9.  Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.

Authors:  Jing Zhao; Bin Xu; Xi Huang; Yi Yan; Yanping Li
Journal:  Reprod Health       Date:  2020-11-20       Impact factor: 3.223

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.